🔎 Trials Near Me

Hjem › Neuroblastom › Oregon

Kliniske studier for Neuroblastom i Oregon

6 studier for Neuroblastom søker deltakere på steder i Oregon.

Byer i Oregon

Offisiell studietekst (engelsk)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
RekruttererFase 3
Opp til 30 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Oregon Health and Science University ( Site 1004), Portland
RekruttererFase 1/2
6 Months – 25 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06395103

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Randall Children's Hospital, Portland
RekruttererFase 2
Opp til 22 år · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02559778

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Randall Children's Hospital, Portland
RekruttererFase 2
Alder 1 til 21 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Legacy Emanuel Children's Hospital, Portland
RekruttererFase 3
365 Days – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03126916

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Randall Children's Hospital, Portland
RekruttererFase 2
12 Months – 21 Years · Alle kjønn · Oppdatert 12. aug. 2026 · NCT05489887

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.